Application Sponsors
ANDA 203572 | AUROLIFE PHARMA LLC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 0.5MG | 0 | LORAZEPAM | LORAZEPAM |
002 | TABLET;ORAL | 1MG | 0 | LORAZEPAM | LORAZEPAM |
003 | TABLET;ORAL | 2MG | 0 | LORAZEPAM | LORAZEPAM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-12-22 | |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
AUROLIFE PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 203572
[companyName] => AUROLIFE PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"0.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LORAZEPAM","activeIngredients":"LORAZEPAM","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/22\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-12-22
)
)